Nanexa AB Revenue and Competitors
Estimated Revenue & Valuation
- Nanexa AB's estimated annual revenue is currently $2.5M per year.
- Nanexa AB's estimated revenue per employee is $98,000
Employee Data
- Nanexa AB has 25 Employees.
- Nanexa AB grew their employee count by -22% last year.
Nanexa AB's People
Name | Title | Email/Phone |
---|
Nanexa AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $223.4M | 1116 | 5% | $65M | N/A |
#2 | $13.6M | 97 | 2% | $23.1M | N/A |
#3 | $1.1M | 13 | N/A | N/A | N/A |
#4 | $87.5M | 492 | -4% | $206M | N/A |
#5 | $41.9M | 272 | 18% | N/A | N/A |
#6 | $53.4M | 305 | 22% | N/A | N/A |
#7 | $55.8M | 314 | -5% | $102.6M | N/A |
#8 | $13.6M | 97 | 13% | N/A | N/A |
#9 | $0.2M | 3 | N/A | N/A | N/A |
#10 | $2.8M | 29 | N/A | N/A | N/A |
What Is Nanexa AB?
Nanexa AB is a drug delivery company that focuses on the development of PharmaShell®, a new and pioneering drug delivery system that is considered to have great potential in a number of substance types and indication areas. Within the framework of PharmaShell®, Nanexa develops its own projects and has collaborative agreements with several pharmaceutical companies, including AstraZeneca.
keywords:N/AN/A
Total Funding
25
Number of Employees
$2.5M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nanexa AB News
2022-04-17 - Nanexa publishes interim report for January March 2022
Nanexa AB was granted a patent in the US (US 11,214,865 B2) for an ALD reactor adapted for large-scale production of PharmaShell®-coated...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 25 | 32% | N/A |
#2 | $3.9M | 27 | 17% | N/A |
#3 | $6.8M | 34 | N/A | N/A |
#4 | $7.2M | 36 | -3% | N/A |
#5 | $4.1M | 37 | 32% | N/A |